Neuromuscular Blocking Agents: Clinical Trials

1 trial for Neuromuscular Blocking Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Neuromuscular Blocking Agents: new trials by email Literature Review of Neuromuscular Blocking Agents trials Research Report on Neuromuscular Blocking Agents

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
Sugammadex 1 mg/kg, Neostigmine + Atropine - Neuromuscular Blocking Agents, Reversal of Neuromuscular Blockade
Phase 1 / Phase 2RecruitingUniversitas Padjadjaran602024-11-052025-01-28

Interventions

Atropine (1)  ·  Neostigmine (1)  ·  Sugammadex (1)

Sponsors

Universitas Padjadjaran (1)

Countries

Indonesia (1)

Top investigators

Tini T Maskoen, M.D. (1)